
France · Pharmaceuticals startup
H2 PHARMA FRANCE is a prominent French company specializing in pharmaceutical manufacturing, particularly in the development and production of generic drugs and non-prescription liquid pharmaceuticals.
Funding reportedLast round: Private equity
H2 PHARMA FRANCE is a prominent French company specializing in pharmaceutical manufacturing, particularly in the development and production of generic drugs and non-prescription liquid pharmaceuticals.
Established in 2009 and based in Bois-d'Arcy, Île-de-France, the company is recognized for its expertise in non-sterile liquid pharmaceutical specialties. H2 PHARMA operates as a self-owned entity and employs between 36 to 100 people. The company manages the entire drug value chain, from sourcing active ingredients to pharmaceutical development, manufacturing, and quality control. H2 PHARMA offers a range of services, including active ingredient sourcing, formulation design, regulatory affairs support, and large-scale production of liquid medications. Its product portfolio features syrups, oral solutions, mouthwashes, suspensions, and external use solutions, with a notable capability in producing alcohol-based formulations safely. With plans to double its production output, H2 PHARMA currently manufactures around 50 million units annually, positioning itself as a key partner for French generic drug manufacturers and OTC laboratories.
Funding, as reported
What they build
Known for
health careliquid pharmaceutical specialtiesmanufacturingpharmaceutical developmentclean room manufacturingfacility managementlogistics & supply chainbatch productionmouthwashpartenaire privilegieregulatory affairshospital & health caremedicalhealthcontract manufacturingmechanical or industrial engineering
Built with from their website
Contact Form 7Google Tag ManagerWordPress.orgHREF LangOVHcloudFont AwesomeApacheYouTubeViewport MetaElement UI
Priority HintsCAPTCHAGoogle Font APIMicrosoft ExchangeFitVids.JSReally Simple CAPTCHAMixitupMySQL
Add your raise, your deck and your story, and put H2 PHARMA FRANCE in front of investors. Or tell us what we have wrong.